Stanley Lapidus, Director at T2 Biosystems, Inc. (TTOO), sold 9,000 shares at $1.44 ($13K) on 2019-06-11, disclosed to the SEC on 2019-06-13.
Scheduled sale ($13k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| LUCD | SELL | 2022-09-22 | $58K | — | Filing → |
| TTOO | SELL | 2018-11-08 | $32K | — | Filing → |
| TTOO | SELL | 2018-06-05 | $53K | — | Filing → |